Reduced Normal Tissue Doses Through Advanced Technology
Re-irradiation is probably the most challenging situation in radiotherapy because the radiation tolerance of the normal tissue is significantly reduced compared with the first treatment series. Results with traditional radiotherapy techniques have been disappointing because of the poor conformality of the dose distributions: radiation doses were either insufficiently low resulting in poor rates of tumor control or substantial toxicity was the consequence of high-dose re-irradiation. This chapter will focus on modern techniques of radiation treatment planning and delivery, which make improved sparing of the normal tissue possible. All techniques will be discussed in the context of re-irradiation and theoretical and clinical data supporting the use of these technologies will be presented. Palliative reirradiation to moderate doses might be feasible without using advanced technology. However, under many circumstances 2D or 3D conformal approaches can not fulfill the required normal tissue constraints. The present chapter discusses the advantages and challenges associated with more complex planning and delivery methods.
KeywordsTarget Volume Planning Target Volume Dose Distribution Clinical Target Volume Gross Tumor Volume
- ICRU (1993) International commission on radiation units and measurements: prescribing, recording and reporting photon beam therapy, report 50. ICRU, BethesdaGoogle Scholar
- ICRU (1999) International commission on radiation units and measurements: prescribing, recording and reporting photon beam therapy, report 62. ICRU, BethesdaGoogle Scholar
- Kelly P et al (2010) Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys (Epub ahead of print)Google Scholar
- Poltinnikov IM et al (2005) Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame. Int J Radiat Oncol Biol Phys 62(3):652–658PubMedCrossRefGoogle Scholar
- Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, Ozhasoglu C, Burton S (2010) Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Am J Clin Oncol 33(3):286–293.PubMedGoogle Scholar